Class II · Moderate risk
Cathflo activase
Lack of Assurance of Sterility: Deformed stoppers observed during filling operations for Cathflo Activase.
National Drug Code
Is NDC 50242-0041-64 recalled?
Cathflo Activase · 1 VIAL in 1 CARTON (50242-041-64) / 2 mL in 1 VIAL
Yes — this exact package was recalled
2 FDA recalls name the code 50242-0041-64 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.
- Active ingredient
- Alteplase
- Strength
- ALTEPLASE 2.2 mg/2mL
- Form
- Injection, Powder, Lyophilized, for Solution · Intravenous
- Labeler
- Genentech, Inc.
- Type
- Human Prescription Drug
- Product code
- 50242-0041
Recalls naming this package
Class II · Moderate risk
cathflo activase
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.
Other recalled products from this labeler
- 50242-0215 Xolair PFS 2
- 50242-0040 Xolair 1
- 50242-0064 See recall 1
- 50242-0074 See recall 1
- 50242-0076 See recall 1
- 50242-0078 Susvimo 1
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.